iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
₹2,265.7
(1.79%)
Oct 27, 2026|03:55:27 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,880₹5.5 -28.57%7,5005.26%
--1,920₹7.5 -20.63%7,8750%
--1,940₹12 0%4,1250%
--1,960₹9.6 -22.89%5,250-41.66%
--1,980₹10.9 -26.1%3,375-25%
1,1250%₹290 15.07%2,000₹11.6 -31.36%9,7508.33%
--2,020₹20.15 0%5,2500%
--2,040--
--2,060--
12,3750%₹168.2 0%2,080₹20.2 -64.27%4,5009.09%
--2,100₹23.5 -31.18%1,30,500-8.90%
7500%₹174.5 0%2,120₹29.25 -27.23%2,625250%
3750%₹152.15 0%2,140₹31.4 -41.85%6,0001500%
14,2500%₹126.75 0%2,160₹35.8 -31.21%11,625-16.21%
9,75023.80%₹140 19.14%2,180--
1,01,250-7.21%₹128 21.15%2,200₹50 -25.42%93,00047.61%
21,750-15.94%₹120.8 25.37%2,220₹57.35 -31.39%5,625150%
22,500328.57%₹106 24.19%2,240₹62.35 -28.04%9,000140%
12,750750%₹92.3 5.6%2,260₹70.8 -26.74%54,00056.52%
31,1254050%₹80 19.4%2,280--
2,75,62580.58%₹70.55 18.67%2,300₹92.5 -22.88%26,62561.36%
2,62540%₹63 35.62%2,320₹120.3 -41.31%750100%
00%₹63.8 0%2,340₹123 -21.4%3,7500%
2,2500%₹48.5 0%2,360₹135.4 -20.35%1,50033.33%
5,6250%₹36.15 5.24%2,380--
1,37,25070.23%₹35.5 13.05%2,400₹163 -11.43%11,625158.33%
7,500-9.09%₹27.65 6.14%2,420--
9,75052.94%₹27.6 12.65%2,440--
10,500154.54%₹24.3 12.76%2,460₹265.6 0%1,1250%
2,2500%₹20.3 0%2,480--
5,62515.38%₹18.15 7.39%2,500--
40,875-8.40%₹15.6 6.84%2,520--
--2,560--
16,50012.82%₹8.95 -2.71%2,600₹440 0%3750%
9,3752400%₹6.35 111.66%2,680₹435 0%2,6250%
00%₹71.2 0%2,720--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.